# BATCH2-CONTEXT-COMPLETION-1 — Runtime Semantics and STOP-Gated Activation

---
work_id: BATCH2-CONTEXT-COMPLETION-1_runtime_semantics_and_stop_gated_activation
branch: work/BATCH2-CONTEXT-COMPLETION-1-runtime-semantics-and-stop-gated-activation
status: IMPLEMENTATION_COMPLETE_NO_ACTIVATION
---

## Executive verdict

Governed disclosed-context semantics are implemented deterministically in `runtime_context_evaluator.py`. Package metadata misclassifications are remediated for 6 packages. All validators and regression tests pass. **No packages were activated** — approval phrase not received; androgen packages remain blocked on CF-BATCH2-010; FT3 low remains blocked on `enable_lower_bound: false`.

---

## Files inspected

- `knowledge_bus/governance/runtime_context_semantics_model_v1.yaml`
- `knowledge_bus/governance/runtime_context_requirements_model_v1.yaml`
- `knowledge_bus/governance/batch2_context_clearance_register_v1.yaml`
- `knowledge_bus/governance/context_runtime_execution_register_v1.yaml`
- `backend/core/analytics/runtime_context_evaluator.py`
- `backend/core/analytics/signal_evaluator.py` (read-only; unchanged)
- All 9 context-dependent Batch 2 `signal_library.yaml` files

---

## Files changed

- `backend/core/analytics/runtime_context_evaluator.py`
- `backend/tests/regression/test_runtime_context_evaluation.py`
- `backend/tests/governance/test_batch2_context_clearance_register.py`
- `knowledge_bus/packages/pkg_kb47_dhea_high_androgen_excess_context/signal_library.yaml`
- `knowledge_bus/packages/pkg_kb47_dhea_low_adrenal_androgen_reduction/signal_library.yaml`
- `knowledge_bus/packages/pkg_kb47_fai_high_biochemical_hyperandrogenism/signal_library.yaml`
- `knowledge_bus/packages/pkg_kb47_free_testosterone_high_androgen_excess_context/signal_library.yaml`
- `knowledge_bus/packages/pkg_kb47_free_testosterone_low_androgen_deficiency_context/signal_library.yaml`
- `knowledge_bus/packages/pkg_kb47_free_t3_low_low_t3_syndrome/signal_library.yaml`
- `knowledge_bus/governance/batch2_context_clearance_register_v1.yaml`
- `knowledge_bus/governance/context_runtime_execution_register_v1.yaml`
- `docs/sprints/launch_core_carry_forward_register.md`

---

## Authority preflight

All 14 authority preflight items confirmed. Single evaluator + single requirements model remain authority. Execution token issued by kernel start.

---

## Reality check

- CF-CONTEXT-SEMANTICS-1: taxonomy resolved; runtime implementation completed in this sprint
- CF-BATCH2-010: Open (no clinical sign-off artefact)
- ARCH-ORCH-RESTRUCTURE-1: Open
- CF-CONTEXT-MOD-3: Resolved
- All 9 packages inactive before and after sprint
- Evaluator did not support `disclosed` at sprint start — now implemented

---

## Runtime implementation summary

Two coordinated changes in `runtime_context_evaluator.py`:

1. **`build_runtime_context_snapshot()`** records disclosure keys (`*_disclosed`, `*_status_disclosed`) when questionnaire fields are answered, independently of positive exposure.
2. **`evaluate_runtime_context_requirements()`** adds `disclosed` requirement mode (fail-closed unless disclosure key is `True`).

Backward compatibility: existing `present` and `lab_range_boundary` branches unchanged.

---

## Package metadata remediation summary

| package_id | change |
|------------|--------|
| pkg_kb47_dhea_high_androgen_excess_context | hormone_therapy/aas_exposure present → disclosed keys |
| pkg_kb47_dhea_low_adrenal_androgen_reduction | long_term_medications/steroid present → disclosed keys |
| pkg_kb47_fai_high_biochemical_hyperandrogenism | hormone_therapy/aas_exposure present → disclosed keys |
| pkg_kb47_free_testosterone_high_androgen_excess_context | long_term_medications/hormone_therapy present → disclosed keys |
| pkg_kb47_free_testosterone_low_androgen_deficiency_context | long_term_medications present → disclosed key |
| pkg_kb47_free_t3_low_low_t3_syndrome | illness_or_recovery_status present → disclosed key |

No changes to signal_id, activation_key, thresholds, or clinical wording.

---

## Activation STOP gate table

| package_id | signal_id | activation_key | status | runtime_context_requirements | clinical sign-off | tests | package validation | activation-layer blockers | recommendation |
|------------|-----------|----------------|--------|------------------------------|-------------------|-------|-------------------|---------------------------|----------------|
| pkg_kb47_dhea_high_androgen_excess_context | signal_dhea_high | signal_dhea_high::inv_dhea_high_androgen_excess_context | inactive | aligned | not_in_repo | PASS | PASS | — | KEEP_INACTIVE_PENDING_CLINICAL_SIGNOFF |
| pkg_kb47_dhea_low_adrenal_androgen_reduction | signal_dhea_low | signal_dhea_low::inv_dhea_low_adrenal_androgen_reduction | inactive | aligned | not_in_repo | PASS | PASS | — | KEEP_INACTIVE_PENDING_CLINICAL_SIGNOFF |
| pkg_kb47_fai_high_biochemical_hyperandrogenism | signal_fai_high | signal_fai_high::inv_fai_high_biochemical_hyperandrogenism | inactive | aligned | not_in_repo | PASS | PASS | — | KEEP_INACTIVE_PENDING_CLINICAL_SIGNOFF |
| pkg_kb47_fai_low_reduced_free_androgen_availability | signal_fai_low | signal_fai_low::inv_fai_low_reduced_free_androgen_availability | inactive | no misclassification | not_in_repo | PASS | n/a | — | KEEP_INACTIVE_PENDING_CLINICAL_SIGNOFF |
| pkg_kb47_free_testosterone_high_androgen_excess_context | signal_free_testosterone_high | signal_free_testosterone_high::inv_free_testosterone_high_androgen_excess_context | inactive | aligned | not_in_repo | PASS | PASS | — | KEEP_INACTIVE_PENDING_CLINICAL_SIGNOFF |
| pkg_kb47_free_testosterone_low_androgen_deficiency_context | signal_free_testosterone_low | signal_free_testosterone_low::inv_free_testosterone_low_androgen_deficiency_context | inactive | aligned | not_in_repo | PASS | PASS | — | KEEP_INACTIVE_PENDING_CLINICAL_SIGNOFF |
| pkg_kb47_free_testosterone_pct_high_elevated_free_androgen_fraction | signal_free_testosterone_pct_high | signal_free_testosterone_pct_high::inv_free_testosterone_pct_high_elevated_free_androgen_fraction | inactive | no misclassification | not_in_repo | PASS | n/a | — | KEEP_INACTIVE_PENDING_CLINICAL_SIGNOFF |
| pkg_kb47_free_testosterone_pct_low_reduced_free_androgen_fraction | signal_free_testosterone_pct_low | signal_free_testosterone_pct_low::inv_free_testosterone_pct_low_reduced_free_androgen_fraction | inactive | no misclassification | not_in_repo | PASS | n/a | — | KEEP_INACTIVE_PENDING_CLINICAL_SIGNOFF |
| pkg_kb47_free_t3_low_low_t3_syndrome | signal_free_t3_low | signal_free_t3_low::inv_free_t3_low_low_t3_syndrome | inactive | aligned | thyroid deferred | PASS | PASS | enable_lower_bound: false | DO_NOT_ACTIVATE |

**Approval phrase received:** No

**Packages activated:** 0

---

## Confirmations

- No unauthorised activation occurred
- No thresholds changed
- No reference range policy changed
- No signal IDs changed
- No activation keys changed
- No frontend changed
- No SSOT changed
- No scoring changed
- No report compiler changed
- `signal_evaluator.py` unchanged

---

## Validator output

```
architecture_validation_gate: PASS
validation_status: PASS (medical_frame_identity_index)
validation_status: PASS (context_modifier_catalogue)
```

---

## Test output

```
pytest backend/tests/regression/test_runtime_context_evaluation.py -q → 19 passed
pytest backend/tests/governance/test_runtime_context_semantics_model.py -q → 4 passed
pytest backend/tests/governance/test_batch2_context_clearance_register.py -q → 6 passed
```

Package validators: PASS for all 6 touched packages.

---

## Rollback path

Revert `runtime_context_evaluator.py` disclosed branch and snapshot disclosure keys; revert remediated `signal_library.yaml` files; revert governance registers, tests, audit papers, and carry-forward register.

---

## Residual architectural observations

- `thyroid_medication_disclosed` required by clearance register for FT3 low is not yet in package metadata (non-misclassification gap).
- `ARCH-ORCH-RESTRUCTURE-1` remains open — orchestrator phase ordering unchanged.
- Stale `remediation_work_id` in semantics model references BATCH2-CONTEXT-ACTIVATION-1 naming.

---

## Recommended next action

Resolve androgen clinical sign-off evidence (CF-BATCH2-010) before any STOP-gated activation. FT3 low requires explicit `enable_lower_bound` review during activation phase if ever considered.
